Stress echocardiography versus myocardial SPECT for risk stratification of patients with coronary artery disease

Current Opinion in Cardiology

Volumn 18, Issue 6, 2003, Pages 486-493

  Maganti, Kameswari ^a,b   Rigolin, Vera H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NW Medical Faculty Foundation ^*  (United States)

Author keywords

Coronary artery disease; SPECT imaging; Stress echo

Indexed keywords

DOBUTAMINE; FIBRINOLYTIC AGENT; FLUORODEOXYGLUCOSE; GLYCERYL TRINITRATE;

ACUTE HEART INFARCTION; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART INFARCTION; HUMAN; ISCHEMIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRATIFICATION;

CARDIOMYOPATHIES; CORONARY ARTERIOSCLEROSIS; ECHOCARDIOGRAPHY, STRESS; HUMANS; PROGNOSIS; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; UNITED STATES;

EID: 1342280446     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200311000-00010     Document Type: Review

References (59)

1. Olmos LI, Dakik H, Gordon R, et al.: Long-term prognostic value of exercise echocardiography compared with exercise 201 TI, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation 1998, 98:2629-2686.
2. Reishmann KE, Hunink MGM, Kuntz KM, et al.: Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 1998, 280:913-920.
3. Sawada SG, Segar DS, Ryan T, et al.: Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991, 83:1605-1614.
4. Kim C, Kwok YS, Heagerty P, et al.: Pharmacologic stress testing for coronary disease diagnosis: a meta-analysis. Am Heart J 2001, 142:934-944.
5. Marwick T, D'Hondt AM, Baudhuin T, et al.: Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 1993, 22:159-167.
6. Hansen C, Crabbe D, Rubin S, et al.: Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women: an effect of smaller chamber size. J Am Coll Cardiol 1996, 28:1214-1219.
7. Santana-Boado C, Candell-Riera J, Castell-Conesa, et al.: Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men. J Nucl Med 1998, 39:751-755.
8. Friedman T, Greene A, Iskandrian A, et al.: Exercise thallium-201 myocardial perfusion scintigraphy in women: correlation with coronary angiography. Am J Cardiol 1982, 49:1632-1637.
9. Amanullah A, Berman D, Hachamovitch R, et al.: Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT. Am J Cardiol 1997, 89:132-137.
10. Iskandrian A, Heo J, Nallamothu N: Detection of coronary artery disease in women with use of single-photon emission computed tomography myocardial perfusion imaging. J Nucl Cardiol 1997, 4:329-335.
11. Marwick TH, Nemec JJ, Pashkow FJ, et al.: Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol 1992, 19:82-83.
12. Marwick TH, Anderson T, Williams MJ, et al.: Exercise echocardiography is an accurate and cost-effective technique for detection of coronary artery disease in women. J Am Coll Cardiol 1995, 26:335-341.
13. Elhendy A, Gelejinse M, Van Domburg R, et al.: Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease. Am J Cardiol 1997, 80:1414-1418.
14. Hachamovitch R, Berman DS, Kiat H, et al.: Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996, 93:905-914.
15. Diaz L, Brunken R, Blackstone E, et al.: Independent contribution of myocardial perfusion defects to exercise capacity and heart rate recovery for prediction of all-cause mortality in patients with known or suspected coronary heart disease. J Am Coll Cardiol 2001, 37:1558-1564.
16. Krivokapich J, Child JS, Gerber RS, et al.: Prognostic usefulness of positive or negative exercise stress echocardlography for predicting coronary events in ensuing twelve months. Am J Cardiol 1993, 71:646-651.
17. Marwick TH, Mehta R, Arheart K, et al.: Use of exercise echocardiography for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol 1997, 30:83-90.
18. McCully RB, Roger VL, Mahoney DW, et al.: Outcome after abnormal exercise echocardiography for patients with good exercise capacity. J Am Coll Cardiol 2002, 39:1345-1352. This study discussed the clinical outcomes in 1824 patients with suspected CAD and good exercise capacity. The extent and severity of exercise-related left ventricular dysfunction were of independent and incremental prognostic value.
19. Sicari R, Pasanisi E, Venneri L, et al.: Stress echo results predict mortality: a large scale multicenter prospective international study. J Am Coll Cardiol 2003, 41:589-595. This study revealed that in 7333 patients followed for a period of 2.6 ± 3 years that pharmacologic stress echo is an independent predictor of cardiac death, incremental to other parameters.
20. Marcovitz PA, Shayna V, Horn RA, et al.: Value of dobutamine stress echocardiography in determining the prognosis of patients with known or suspected coronary artery disease. Am J Cardiol 1996, 78:404-408.
21. Shaw LJ, Hendel R, Borges-Neto S, et al.: Prognostic value of normal execise and adenosine(99m) Tc-tetrofosmin SPECT imaging from a large multi-center registry of 4,728 patients. J Nucl Med 2003, 44:134-139. This large multicenter registry provides further supportive evidence that excellent prognosis is associated with a normal SPECT scan and is independent of the radiopharmaceutical agent used.
22. Iskander S, Iskandrian A: Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998, 32:57-62.
23. Vanzetto G, Ormezzano O, Farget D, et al.: Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with a 6 year follow-up. Circulation 1999, 100:1521-1527.
24. Travin MI, Boucher CA, Newell JB, et al.: Variables associated with a poorer prognosis in patients with an ischemic thallium-201 exercise test. Am Heart J 1993, 125:335-344.
25. Marwick T, Case C, Sawada S, et al.: Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol 2001, 37:754-760.
26. McCully R, Roger V, Mahoney D, et al.: Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1, 325 patients. J Am Coll Cardiol 1998, 31:144-149.
27. Afridi I, Quinones MA, Zoghbi WA, et al.: Prognostic value of dobutamine echocardiography in patients with high pretest likelihood of coronary artery disease. Am J Cardiol 1993, 71:33-39.
28. Chuah SC, Pellika PA, Roger VL, et al.: Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation 1998, 97:1474-1480.
29. Steinberg EH, Madmon L, Patel CP, et al.: Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a five year follow-up study. J Am Coll Cardiol 1997, 29:969-973.
30. Dakik HA, Mahmarian JJ, Kimball KT, et al.: Prognostic value of 201 TI tomography in patients treated with thrombolytic therapy during acute myocardial infarction. Circulation 1996, 94:2735-2742.
31. Shaw LJ, Peterson ED, Kesler K, et al.: A meta-analysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging. Am J Cardiol 1996, 78:1327-1337.
32. Ryan T, Armstong WF, O'Donnell JA, et al.: Risk stratification after acute myocardial infarction by means of exercise two-dimensional echocardiography. Am Heart J 1987, 114:1305-1316.
33. Chiamvimonvat V, Goodman SG, Langer A, et al.: Prognostic value of dipyridamole SPECT imaging in low-risk patients after myocardial infarction. J Nucl Cardiol 2001, 8:136-143.
34. Picano E, Pingitore A, Sicari R, et al.: Stress echocardiographic results predict risk of reinfarction early after uncomplicated acute myocardial infarction: large-scale multicenter study. J Am Coll Cardiol 1995, 26:908-913.
35. Quintana M, Lindvall K, Ryden L, et al.: Prognostic value of predischarge exercise stress echocardiography after acute myocardial infarction. Am J Cardiol 1995, 76:1115-1121.
36. Penco M, Sciomer S, Vizza CD, et al.: Clinical impact of echocardiography in prognostic stratification after acute myocardial infarction. Am J Cardiol 1998, 81:17G-20G.
37. Sicari R, Landi P, Picano E, et al.: Exercise electrocardiography and/or pharmacological stress echocardiography for non-invasive risk stratification early after uncomplicated myocardial infarction. A prospective international large-scale multicentre study. Eur Heart J 2002, 23:1030-1037. This study showed that exercise and pharmacologic modalities after a myocardial infarction provide stronger information than historical or exercise echocardiographic variables. The delta wall motion score index and exercise duration were independent predictors of future spontaneous events.
38. Bigi R, Cortigiani L, Mariani P, et al.: Sustained favorable long term prognosis of negative stress echocardiography following uncomplicated myocardial infarction. Am J Cardiol 2002, 90:149-152. This study demonstrates that patients younger than 65 years of age with negative DSE represent an ideal setting in which conservative management could be safely considered because there is a very low incidence of major cardiac events in such patients after an uncomplicated, acute myocardial infarction.
39. Cigarroa CG, de Filippi CR, Brickner ME, et al.: Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993, 88:430-436.
40. Geleijnse ML, Floretti PM, Roelandt J: Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 1997, 30:595-606.
41. Secknus MA, Marwick TH: Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol 1997, 29:1234-1240.
42. Sun KT, Czemin J, Krivokapich J, et al.: Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation 1996, 94:3146-3154.
43. Pierard LA, De Land Sheere CM, Berthe C, et al.: Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990, 15:1021-1031.
44. Bax JJ, Cornel JH, Visser FC, et al.: Prediction of recovery of myocardial dysfunction after revascularization: comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996, 28:558-564.
45. Bonow RO: Identification of viable myocardium. Circulation 1996, 94:2674-2680.
46. Bonow RO: Clinical value of combined assessment of perfusion and function for the evaluation of myocardial viability. In Clinical Gated Cardiac SPECT. Edited by Germano G, Berman DS. Armonk, NY: Futura; 1999:307-324.
47. Arrighi A, Dilsizian V: Myocardial viability-Radionuclidide-based methods. In Imaging in Cardiovascular Disease. Edited by Pohost G, et al. Philadelphia: Lippincott Williams & Wilkins; 2000, 15:213-233.
48. Bax JJ, Wijns W, Cornel JH, et al.: Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997, 30:1451-1460.
49. Gibbons R, Chatterjee K, Daley J, et al.: ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 1999, 33:2092-2197.
50. Allman KC, Shaw U, Hachamovitch R, et al.: Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002, 39:1151-1158. This meta-analysis demonstrates a strong association between myocardial viability on noninvasive testing and improved survival after revascularization in patients with chronic CAD and left ventricular dysfunction.
51. Bonow RO: Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction [editorial comment]. J Am Coll Cardiol 2002, 39:1159-1162. This thought-provoking editorial comment discusses the current limitations of available data in viability assessment in the setting of left ventricular dysfunction and discusses the need for prospective, randomized trials.
52. Afridi I, Main ML, Grayburn PA: Accuracy of dobutamine echocardiography for detection of myocardial viability in patients with occluded left anterior descending artery. J Am Coll Cardiol 1996, 28:432-442.
53. Cornel JH, Bax JJ, Elhendy A, et al.: Diphasic response to dobutamine predicts improvement of left ventricular function after surgical revascularization in patients with stable coronary artery disease. J Am Coll Cardiol 1998, 31:1002-1010.
54. Afridi I, Grayburn PA, Panza JA, et al.: Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol 1998, 32:921-926.
55. Marwick T: Stress echocardiography. Heart 2003, 89:113-118. This is an excellent reference article that discusses the methodology, merits, and utility of individual echocardiographic stress tests.
56. Galli M, Marcassa C, Imparato A, et al.: Enhanced detection of viable myocardium by technetium-99m sestamibi tomoscintigraphy on resting regional myocardial hypoperfusion in stable patients with healed myocardial infarction. Am J Cardiol 1994, 74:843-848.
57. Maurea S, Cuocolo A, Soricelli A, et al.: Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995, 36:1945-1954.
58. Basu S, Senior R, Raval U, et al.: Superiority of nitrate-enhanced 201 TI over conventional redistribution 201 TI imaging for prognostic evaluation after myocardial infarction and thrombolysis. Circulation 1997, 96:2932-2937.
59. He ZX, Medrano R, Hays JT, et al.: Nitroglycerine-augmented 201 TI reinjection enhances detection of reversible myocardial hypoperfusion. A randomized, double blind, parallel, placebo-controlled trial. Circulation 1997, 95:1795-1805.